The trial includes a 48-week primary treatment period, blinded to bimagrumab study drug, followed by a 24-week open-label treatment extension period, and a subsequent 32-week follow-up period after treatment withdrawal
Some researchers theorize that tirzepatide's biased agonism, particularly its stronger GIP activity relative to GLP-1 activity, may produce a different side effect profile that certain people tolerate better
Glucagon-like peptide (GLP-1) GLP-1 is a peptide hormone composed of of 30 or 31 amino acids [9]
When I learned about mazdutide and its dual-action mechanism, I was skeptical
Once-weekly injectable pens deliver higher adherence and steady pharmacokinetics, sustaining 59.73% revenue share in 2025
Tirzepatide (most popular) first month starting dose $299/mo, then all doses $399/mo